Global 23-valent Pneumococcal Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 28 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global 23-valent Pneumococcal Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global 23-valent Pneumococcal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for 23-valent Pneumococcal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 23-valent Pneumococcal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global 23-valent Pneumococcal Vaccine total production and demand, 2018-2029, (K Units)
Global 23-valent Pneumococcal Vaccine total production value, 2018-2029, (USD Million)
Global 23-valent Pneumococcal Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 23-valent Pneumococcal Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 23-valent Pneumococcal Vaccine domestic production, consumption, key domestic manufacturers and share
Global 23-valent Pneumococcal Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 23-valent Pneumococcal Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 23-valent Pneumococcal Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global 23-valent Pneumococcal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sanofipasteur, CDIBP, Kexing Bio, Changsheng Bio-Technology and Huaan Science and Technology Innovation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 23-valent Pneumococcal Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global 23-valent Pneumococcal Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global 23-valent Pneumococcal Vaccine Market, Segmentation by Type
    Single Dose Vial
    Pre-filled Syringe

Global 23-valent Pneumococcal Vaccine Market, Segmentation by Application
    Chronic Cardiovascular Disease
    Chronic Lung Disease
    Chronic Liver Disease
    People Living with Hiv
    Leukemia
    Lymphoma
    Multiple Myeloma
    General Malignancy
    Chronic Kidney Disease
    Other

Companies Profiled:
    Merck
    Sanofipasteur
    CDIBP
    Kexing Bio
    Changsheng Bio-Technology
    Huaan Science and Technology Innovation

Key Questions Answered
1. How big is the global 23-valent Pneumococcal Vaccine market?
2. What is the demand of the global 23-valent Pneumococcal Vaccine market?
3. What is the year over year growth of the global 23-valent Pneumococcal Vaccine market?
4. What is the production and production value of the global 23-valent Pneumococcal Vaccine market?
5. Who are the key producers in the global 23-valent Pneumococcal Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 23-valent Pneumococcal Vaccine Introduction
    1.2 World 23-valent Pneumococcal Vaccine Supply & Forecast
        1.2.1 World 23-valent Pneumococcal Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World 23-valent Pneumococcal Vaccine Production (2018-2029)
        1.2.3 World 23-valent Pneumococcal Vaccine Pricing Trends (2018-2029)
    1.3 World 23-valent Pneumococcal Vaccine Production by Region (Based on Production Site)
        1.3.1 World 23-valent Pneumococcal Vaccine Production Value by Region (2018-2029)
        1.3.2 World 23-valent Pneumococcal Vaccine Production by Region (2018-2029)
        1.3.3 World 23-valent Pneumococcal Vaccine Average Price by Region (2018-2029)
        1.3.4 North America 23-valent Pneumococcal Vaccine Production (2018-2029)
        1.3.5 Europe 23-valent Pneumococcal Vaccine Production (2018-2029)
        1.3.6 China 23-valent Pneumococcal Vaccine Production (2018-2029)
        1.3.7 Japan 23-valent Pneumococcal Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 23-valent Pneumococcal Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 23-valent Pneumococcal Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World 23-valent Pneumococcal Vaccine Demand (2018-2029)
    2.2 World 23-valent Pneumococcal Vaccine Consumption by Region
        2.2.1 World 23-valent Pneumococcal Vaccine Consumption by Region (2018-2023)
        2.2.2 World 23-valent Pneumococcal Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.4 China 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.5 Europe 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.6 Japan 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.7 South Korea 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.8 ASEAN 23-valent Pneumococcal Vaccine Consumption (2018-2029)
    2.9 India 23-valent Pneumococcal Vaccine Consumption (2018-2029)

3 World 23-valent Pneumococcal Vaccine Manufacturers Competitive Analysis
    3.1 World 23-valent Pneumococcal Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World 23-valent Pneumococcal Vaccine Production by Manufacturer (2018-2023)
    3.3 World 23-valent Pneumococcal Vaccine Average Price by Manufacturer (2018-2023)
    3.4 23-valent Pneumococcal Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global 23-valent Pneumococcal Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for 23-valent Pneumococcal Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for 23-valent Pneumococcal Vaccine in 2022
    3.6 23-valent Pneumococcal Vaccine Market: Overall Company Footprint Analysis
        3.6.1 23-valent Pneumococcal Vaccine Market: Region Footprint
        3.6.2 23-valent Pneumococcal Vaccine Market: Company Product Type Footprint
        3.6.3 23-valent Pneumococcal Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: 23-valent Pneumococcal Vaccine Production Value Comparison
        4.1.1 United States VS China: 23-valent Pneumococcal Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: 23-valent Pneumococcal Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: 23-valent Pneumococcal Vaccine Production Comparison
        4.2.1 United States VS China: 23-valent Pneumococcal Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: 23-valent Pneumococcal Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: 23-valent Pneumococcal Vaccine Consumption Comparison
        4.3.1 United States VS China: 23-valent Pneumococcal Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: 23-valent Pneumococcal Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based 23-valent Pneumococcal Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers 23-valent Pneumococcal Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023)
    4.5 China Based 23-valent Pneumococcal Vaccine Manufacturers and Market Share
        4.5.1 China Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers 23-valent Pneumococcal Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023)
    4.6 Rest of World Based 23-valent Pneumococcal Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World 23-valent Pneumococcal Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Single Dose Vial
        5.2.2 Pre-filled Syringe
    5.3 Market Segment by Type
        5.3.1 World 23-valent Pneumococcal Vaccine Production by Type (2018-2029)
        5.3.2 World 23-valent Pneumococcal Vaccine Production Value by Type (2018-2029)
        5.3.3 World 23-valent Pneumococcal Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World 23-valent Pneumococcal Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Chronic Cardiovascular Disease
        6.2.2 Chronic Lung Disease
        6.2.3 Chronic Liver Disease
        6.2.4 People Living with Hiv
        6.2.5 Leukemia
        6.2.6 Lymphoma
        6.2.7 Multiple Myeloma
        6.2.8 General Malignancy
        6.2.9 Chronic Kidney Disease
        6.2.10 Other
    6.3 Market Segment by Application
        6.3.1 World 23-valent Pneumococcal Vaccine Production by Application (2018-2029)
        6.3.2 World 23-valent Pneumococcal Vaccine Production Value by Application (2018-2029)
        6.3.3 World 23-valent Pneumococcal Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck 23-valent Pneumococcal Vaccine Product and Services
        7.1.4 Merck 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Sanofipasteur
        7.2.1 Sanofipasteur Details
        7.2.2 Sanofipasteur Major Business
        7.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Product and Services
        7.2.4 Sanofipasteur 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Sanofipasteur Recent Developments/Updates
        7.2.6 Sanofipasteur Competitive Strengths & Weaknesses
    7.3 CDIBP
        7.3.1 CDIBP Details
        7.3.2 CDIBP Major Business
        7.3.3 CDIBP 23-valent Pneumococcal Vaccine Product and Services
        7.3.4 CDIBP 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 CDIBP Recent Developments/Updates
        7.3.6 CDIBP Competitive Strengths & Weaknesses
    7.4 Kexing Bio
        7.4.1 Kexing Bio Details
        7.4.2 Kexing Bio Major Business
        7.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Product and Services
        7.4.4 Kexing Bio 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kexing Bio Recent Developments/Updates
        7.4.6 Kexing Bio Competitive Strengths & Weaknesses
    7.5 Changsheng Bio-Technology
        7.5.1 Changsheng Bio-Technology Details
        7.5.2 Changsheng Bio-Technology Major Business
        7.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product and Services
        7.5.4 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Changsheng Bio-Technology Recent Developments/Updates
        7.5.6 Changsheng Bio-Technology Competitive Strengths & Weaknesses
    7.6 Huaan Science and Technology Innovation
        7.6.1 Huaan Science and Technology Innovation Details
        7.6.2 Huaan Science and Technology Innovation Major Business
        7.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product and Services
        7.6.4 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Huaan Science and Technology Innovation Recent Developments/Updates
        7.6.6 Huaan Science and Technology Innovation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 23-valent Pneumococcal Vaccine Industry Chain
    8.2 23-valent Pneumococcal Vaccine Upstream Analysis
        8.2.1 23-valent Pneumococcal Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of 23-valent Pneumococcal Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 23-valent Pneumococcal Vaccine Production Mode
    8.6 23-valent Pneumococcal Vaccine Procurement Model
    8.7 23-valent Pneumococcal Vaccine Industry Sales Model and Sales Channels
        8.7.1 23-valent Pneumococcal Vaccine Sales Model
        8.7.2 23-valent Pneumococcal Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World 23-valent Pneumococcal Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World 23-valent Pneumococcal Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World 23-valent Pneumococcal Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World 23-valent Pneumococcal Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World 23-valent Pneumococcal Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World 23-valent Pneumococcal Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World 23-valent Pneumococcal Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World 23-valent Pneumococcal Vaccine Production Market Share by Region (2018-2023)
    Table 9. World 23-valent Pneumococcal Vaccine Production Market Share by Region (2024-2029)
    Table 10. World 23-valent Pneumococcal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World 23-valent Pneumococcal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. 23-valent Pneumococcal Vaccine Major Market Trends
    Table 13. World 23-valent Pneumococcal Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World 23-valent Pneumococcal Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World 23-valent Pneumococcal Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World 23-valent Pneumococcal Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key 23-valent Pneumococcal Vaccine Producers in 2022
    Table 18. World 23-valent Pneumococcal Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key 23-valent Pneumococcal Vaccine Producers in 2022
    Table 20. World 23-valent Pneumococcal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global 23-valent Pneumococcal Vaccine Company Evaluation Quadrant
    Table 22. World 23-valent Pneumococcal Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and 23-valent Pneumococcal Vaccine Production Site of Key Manufacturer
    Table 24. 23-valent Pneumococcal Vaccine Market: Company Product Type Footprint
    Table 25. 23-valent Pneumococcal Vaccine Market: Company Product Application Footprint
    Table 26. 23-valent Pneumococcal Vaccine Competitive Factors
    Table 27. 23-valent Pneumococcal Vaccine New Entrant and Capacity Expansion Plans
    Table 28. 23-valent Pneumococcal Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China 23-valent Pneumococcal Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China 23-valent Pneumococcal Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China 23-valent Pneumococcal Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers 23-valent Pneumococcal Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers 23-valent Pneumococcal Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share (2018-2023)
    Table 37. China Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers 23-valent Pneumococcal Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers 23-valent Pneumococcal Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based 23-valent Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share (2018-2023)
    Table 47. World 23-valent Pneumococcal Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World 23-valent Pneumococcal Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World 23-valent Pneumococcal Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World 23-valent Pneumococcal Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World 23-valent Pneumococcal Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World 23-valent Pneumococcal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World 23-valent Pneumococcal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World 23-valent Pneumococcal Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World 23-valent Pneumococcal Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World 23-valent Pneumococcal Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World 23-valent Pneumococcal Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World 23-valent Pneumococcal Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World 23-valent Pneumococcal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World 23-valent Pneumococcal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Merck Basic Information, Manufacturing Base and Competitors
    Table 62. Merck Major Business
    Table 63. Merck 23-valent Pneumococcal Vaccine Product and Services
    Table 64. Merck 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Merck Recent Developments/Updates
    Table 66. Merck Competitive Strengths & Weaknesses
    Table 67. Sanofipasteur Basic Information, Manufacturing Base and Competitors
    Table 68. Sanofipasteur Major Business
    Table 69. Sanofipasteur 23-valent Pneumococcal Vaccine Product and Services
    Table 70. Sanofipasteur 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Sanofipasteur Recent Developments/Updates
    Table 72. Sanofipasteur Competitive Strengths & Weaknesses
    Table 73. CDIBP Basic Information, Manufacturing Base and Competitors
    Table 74. CDIBP Major Business
    Table 75. CDIBP 23-valent Pneumococcal Vaccine Product and Services
    Table 76. CDIBP 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. CDIBP Recent Developments/Updates
    Table 78. CDIBP Competitive Strengths & Weaknesses
    Table 79. Kexing Bio Basic Information, Manufacturing Base and Competitors
    Table 80. Kexing Bio Major Business
    Table 81. Kexing Bio 23-valent Pneumococcal Vaccine Product and Services
    Table 82. Kexing Bio 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kexing Bio Recent Developments/Updates
    Table 84. Kexing Bio Competitive Strengths & Weaknesses
    Table 85. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
    Table 86. Changsheng Bio-Technology Major Business
    Table 87. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product and Services
    Table 88. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Changsheng Bio-Technology Recent Developments/Updates
    Table 90. Huaan Science and Technology Innovation Basic Information, Manufacturing Base and Competitors
    Table 91. Huaan Science and Technology Innovation Major Business
    Table 92. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product and Services
    Table 93. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Global Key Players of 23-valent Pneumococcal Vaccine Upstream (Raw Materials)
    Table 95. 23-valent Pneumococcal Vaccine Typical Customers
    Table 96. 23-valent Pneumococcal Vaccine Typical Distributors
List of Figure
    Figure 1. 23-valent Pneumococcal Vaccine Picture
    Figure 2. World 23-valent Pneumococcal Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World 23-valent Pneumococcal Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World 23-valent Pneumococcal Vaccine Production (2018-2029) & (K Units)
    Figure 5. World 23-valent Pneumococcal Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World 23-valent Pneumococcal Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World 23-valent Pneumococcal Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America 23-valent Pneumococcal Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe 23-valent Pneumococcal Vaccine Production (2018-2029) & (K Units)
    Figure 10. China 23-valent Pneumococcal Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan 23-valent Pneumococcal Vaccine Production (2018-2029) & (K Units)
    Figure 12. 23-valent Pneumococcal Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World 23-valent Pneumococcal Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India 23-valent Pneumococcal Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of 23-valent Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for 23-valent Pneumococcal Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for 23-valent Pneumococcal Vaccine Markets in 2022
    Figure 26. United States VS China: 23-valent Pneumococcal Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: 23-valent Pneumococcal Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: 23-valent Pneumococcal Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers 23-valent Pneumococcal Vaccine Production Market Share 2022
    Figure 32. World 23-valent Pneumococcal Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World 23-valent Pneumococcal Vaccine Production Value Market Share by Type in 2022
    Figure 34. Single Dose Vial
    Figure 35. Pre-filled Syringe
    Figure 36. World 23-valent Pneumococcal Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World 23-valent Pneumococcal Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World 23-valent Pneumococcal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World 23-valent Pneumococcal Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World 23-valent Pneumococcal Vaccine Production Value Market Share by Application in 2022
    Figure 41. Chronic Cardiovascular Disease
    Figure 42. Chronic Lung Disease
    Figure 43. Chronic Liver Disease
    Figure 44. People Living with Hiv
    Figure 45. Leukemia
    Figure 46. Lymphoma
    Figure 47. Multiple Myeloma
    Figure 48. General Malignancy
    Figure 49. Chronic Kidney Disease
    Figure 50. World 23-valent Pneumococcal Vaccine Production Market Share by Application (2018-2029)
    Figure 51. World 23-valent Pneumococcal Vaccine Production Value Market Share by Application (2018-2029)
    Figure 52. World 23-valent Pneumococcal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 53. 23-valent Pneumococcal Vaccine Industry Chain
    Figure 54. 23-valent Pneumococcal Vaccine Procurement Model
    Figure 55. 23-valent Pneumococcal Vaccine Sales Model
    Figure 56. 23-valent Pneumococcal Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 57. Methodology
    Figure 58. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global 23-valent Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global 23-valent Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global 23-valent Pneumococcal Vaccine market size was valued at USD 1481.7 million in 2023 and is forecast to a readjusted size of USD 1977.7 million by 2030 with a CAGR of 4.2% during review period.

Product Tags

23-valent Pneumococcal Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>